Orsiro From BIOTRONIK, Industry’s First Hybrid Drug-Eluting Stent, Performs as Best in Class

Positive 9 Month Results From BIOFLOW-II Clinical Trial and 12 Month Results From BIOFLOW-III Registry Presented at EuroPCR Congress

BUELACH, SWITZERLAND–(Marketwired – May 31, 2013) – Primary end-point results from the BIOFLOW-II Clinical Study demonstrating …

"Orsiro From BIOTRONIK, Industry’s First Hybrid Drug-Eluting Stent, Performs as Best in Class"

أجهزة بيوترونيك Ilesto 7 ICD/CRT-D Series بتكنولوجيا (R) ProMRI تحصل على اعتماد الجودة الأوروبية

برلين–(Marketwire – 18 فبراير 2013) – أعلنت اليوم BIOTRONIK  (بيوترونيك) الرائدة في مجال تصنيع التقنيات الطبية لمرضى القلب في أعقاب احتفالها بالذكرى السنوية رقم 50 في عام 2013 عن حصول أجهزة Ilesto 7 الخاصة ب…

"أجهزة بيوترونيك Ilesto 7 ICD/CRT-D Series بتكنولوجيا (R) ProMRI تحصل على اعتماد الجودة الأوروبية"

BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval

BERLIN–(Marketwire – February 15, 2013) –  BIOTRONIK, the leading manufacturer of cardiovascular medical technology that is celebrating its 50th anniversary in 2013, announced today that the Ilesto 7 implantable cardioverter-defibrillator/cardiac

"BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval"

Successful HBI and BIOTRONIK Partnership Saves 1,000 Lives – Now Reaching Out to More Countries

BIOTRONIK Renews Commitment After Achieving Their First Milestone of Providing 1,000 Life Saving Devices One Year Earlier Than Expected

BERLIN–(Marketwire – October 1, 2012) –  BIOTRONIK, a leading manufacturer of innovative medical technology, has …

"Successful HBI and BIOTRONIK Partnership Saves 1,000 Lives – Now Reaching Out to More Countries"